In a Quiet Corner of the Market, the Overlooked XCEM Delivers
By the close of June 3, 2026, XCEM, the overlooked EM Core ex-China ETF, logged a 38% gain for the year. In the same period, the SPDR S&P 500 ETF, commonly used as a benchmark for U.S. equities, climbed roughly 11%. The contrast is sharp enough that a $50,000 allocation planted in XCEM at the start of the year would be about $19,000 richer today versus the same money left in SPY. Yet the narrative has largely flown under the radar among retail chatter and many online forums.
The price path paints a simple, powerful story: XCEM’s price rose from around $38.36 at the start of 2026 to about $53.06 by June’s first week. SPY moved from around $680 to the mid-750s over the same span. These are price-only numbers that incorporate dividends and distributions for XCEM, effectively reflecting total return in a single figure. Seen in this light, XCEM’s year-to-date performance is eye-catching, even if it doesn’t grab headlines like a flashier U.S. tech rally.
What Is Driving the Move
Three macro threads converged in the first five months of 2026, lifting XCEM’s framework and helping the fund capture upside in EM growth without the China policy risk that often weighs on that area.
First, an AI and tech capex cycle anchored by demand in semiconductor supply chains and cloud infrastructure pressured EM exporters to reallocate budgets toward regions seen as leaner on policy risk. In practical terms, that means India, Korea, and Taiwan have become bigger pieces of the EM growth story, while mainland Chinese and Hong Kong equities have provided less support for clean upside in the near term.
Second, investors pared risk in large parts of the China consumer space, seeking opportunities in consumption and industrials that benefit from rising middle-class incomes in India and other parts of Asia. That shift matters for XCEM because its beta thematic approach emphasizes growth sectors across Emerging Markets ex China rather than the mainland China megastory alone.
Third, the currency backdrop helped international buyers. With some EM currencies firming against the dollar and commodity prices holding, the total return story for XCEM’s holdings—weighted toward India, Korea, and Taiwan—appeared even more compelling for global money managers hunting alpha in a mixed macro environment.
Portfolio Spotlight: What XCEM Owns
XCEM tracks the Beta Thematic Emerging Markets ex-China index, which targets the higher-growth pockets of EMs without the stability risk believers associate with China-heavy exposure. As of February 2026 filings, the fund’s largest country weights sit in India, South Korea, and Taiwan, with Taiwan Semiconductor Manufacturing among its top single names. The allocation approach is designed to tilt toward technology, consumer, and financials that show resilience in a midcycle recovery, even as China-origin policy risk remains parked on the radar.
For investors evaluating XCEM, the practical takeaway is that the fund exposes you to the EM growth arc you want—without being tethered to a China-centric policy risk that has unsettled markets in recent years.
What the Data Really Says
- Year-to-date return as of June 3, 2026: XCEM up about 38%; SPY up roughly 11%.
- Trailing 12 months: XCEM up about 71%; SPY up around 27%.
- Five-year window shows a mixed picture: XCEM up roughly 76%, SPY up about 78% over the same span, underscoring how XCEM’s gains have concentrated in the most recent year.
- Top weights: India, South Korea, and Taiwan, with Taiwan’s semiconductor sector featuring prominently among core holdings.
- Starting point versus current price: a dollar invested at year-end 2025 would be worth about $1.38 on June 3, 2026 for XCEM, compared with about $1.11 for a dollar invested in SPY.
Plain Talk From Market Voices
Market observers describe the移olig regime shift as a regime trade finally finding its footing. Maria Chen, senior strategist at NorthBridge Capital, says, The current setup favors growth-oriented exposures in India and broader Asia, where earnings visibility is improving and policy reactions remain measured. The result is a more favorable risk-reward profile for ETFs like XCEM.
Raj Patel, an economist at NorthBridge, adds, This is a clear case of an overlooked (xcem) what took moment for some investors to recognize. The balance of policy risk and growth in EM ex China has shifted, creating a window where selective exposure to tech, energy, and consumer sectors can deliver outsized gains relative to a diversified U.S. equity sleeve.
Risks to Watch
Despite the recent strength, XCEM is not immune to the usual EM volatility. Currency moves, trade tensions, and regional inflation can all compress returns if development cycles slow or policy missteps appear in major economies. A stronger dollar or rising dollar funding costs could weigh on external demand for EM exporters. In addition, any renewed emphasis on China’s tech or property sector policy could alter relative performance between ex-China equities and mainland shares.
Investors should consider the concentration risk in India and Taiwan, where a handful of large names can swing performance more than a broad index. As with all thematic exposure, a disciplined rebalancing plan and clear risk tolerance are essential to avoid a concentration drag when regime conditions shift.
Bottom Line for Investors
The year 2026 has delivered a striking split in how investors position around the globe. The overlooked XCEM ETF has risen to the fore by delivering a clean bet on EM growth minus the China policy drag. For portfolios seeking to diversify with a growth tilt and to sidestep pure mega-cap risk, XCEM offers a compelling, albeit not risk-free, path forward. The question many will ask in the coming months is whether this is a lasting regime shift or a five-month phase that becomes a chapter in a longer, more complex market narrative.
Key Takeaways
- XCEM has surged 38% year-to-date, outperforming the S&P 500 by a wide margin as of June 3, 2026.
- The fund’s exposure centers on EM growth opportunities in India, South Korea, and Taiwan, avoiding China-centric policy risk.
- Longer-term results show that much of XCEM’s alpha has arrived in the last 12 months, highlighting a regime-driven rally rather than steady compounding.
Discussion